Contrast Agents for Hepatocellular Carcinoma Imaging: Value and Progression

Area of Science:

• Oncology
• Radiology
• Medical Imaging

Background:

• Hepatocellular carcinoma (HCC) is a major global cancer with high mortality.
• Early diagnosis of HCC is crucial for improving patient prognosis.
• Non-invasive medical imaging, particularly contrast media (CM)-enhanced scans, is key for early HCC detection.

Purpose of the Study:

• To provide a comprehensive overview of contrast media (CM) used in hepatocellular carcinoma (HCC) diagnosis.
• To guide physicians and radiologists in selecting appropriate imaging approaches and CM for HCC.
• To discuss current research and future potential of CM agents in HCC management.

Main Methods:

• Review of current clinical practices for CM use in HCC imaging.
• Analysis of the roles of various CM in different imaging modalities.
• Exploration of ongoing research and development of novel CM agents.

Main Results:

• Different CM offer distinct advantages for specific imaging techniques in HCC diagnosis.
• Combined imaging modalities utilizing various CM can enhance diagnostic accuracy.
• Current research focuses on developing advanced CM for improved HCC detection and characterization.

Conclusions:

• A clear understanding of CM properties is essential for effective HCC diagnosis and treatment.
• Navigating the landscape of available and emerging CM aids in optimizing patient care.
• Future CM research holds promise for further advancements in HCC prognosis.